ProPhase Labs, Inc.

NASDAQ:PRPH

2.45 (USD) • At close September 18, 2024
Bedrijfsnaam ProPhase Labs, Inc.
Symbool PRPH
Munteenheid USD
Prijs 2.45
Beurswaarde 46,742,325
Dividendpercentage 0%
52-weken bereik 2.04 - 7.48
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Ted William Karkus
Website https://www.prophaselabs.com

An error occurred while fetching data.

Over ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL

Vergelijkbare Aandelen

Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd.

SLGL

0.648 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

PDS Biotechnology Corporation logo

PDS Biotechnology Corporation

PDSB

3.07 USD

Spok Holdings, Inc. logo

Spok Holdings, Inc.

SPOK

15.27 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.66 USD

scPharmaceuticals Inc. logo

scPharmaceuticals Inc.

SCPH

5.43 USD

Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

ABOS

2.44 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)